Current status of and strategies for hepatitis C control in South Korea
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Beom Kyung | - |
dc.contributor.author | Jang, Eun Sun | - |
dc.contributor.author | Kim, Jeong Han | - |
dc.contributor.author | Park, Soo Young | - |
dc.contributor.author | Ahn, Song Vogue | - |
dc.contributor.author | Kim, Hyung Joon | - |
dc.contributor.author | Kim, Do Young | - |
dc.date.available | 2019-03-08T07:57:59Z | - |
dc.date.issued | 2017-09 | - |
dc.identifier.issn | 2287-2728 | - |
dc.identifier.issn | 2287-285X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/4005 | - |
dc.description.abstract | Chronic hepatitis C (CHC) is caused by hepatitis C virus (HCV) infection. HCV infection causes acute hepatitis, and the majority of those infected progress to chronic hepatitis, and some of them develop cirrhosis and hepatocellular carcinoma. Transmission of HCV is parenteral, and the major transmission routes include drug abuse, insecure injections or medical procedures, contaminated syringes or needles, sexual contact with an HCV-infected person, vertical infection of newborns by infected mothers, the transfusion of blood or blood products contaminated with viruses, and organ transplants. As no vaccine against HCV is available, HCV management involves blocking routes of transmission transmission, screening for HCV infection, and protecting liver disease progression by treatment. Highly potent oral direct antiviral agents are now available. Therefore, early detection through nation-wide screening program and appropriate treatment should be implemented to improve the quality of life of patients with HCV. Furthermore, for the effective HCV control in South Korea, The organization of an 'integrated national viral hepatitis control system' is desirable. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | KOREAN ASSOC STUDY LIVER | - |
dc.title | Current status of and strategies for hepatitis C control in South Korea | - |
dc.type | Article | - |
dc.identifier.doi | 10.3350/cmh.2017.0105 | - |
dc.identifier.bibliographicCitation | CLINICAL AND MOLECULAR HEPATOLOGY, v.23, no.3, pp 212 - 218 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.wosid | 000411488100004 | - |
dc.identifier.scopusid | 2-s2.0-85050580029 | - |
dc.citation.endPage | 218 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 212 | - |
dc.citation.title | CLINICAL AND MOLECULAR HEPATOLOGY | - |
dc.citation.volume | 23 | - |
dc.type.docType | Review | - |
dc.publisher.location | 대한민국 | - |
dc.subject.keywordAuthor | Hepatitis C virus | - |
dc.subject.keywordAuthor | Status | - |
dc.subject.keywordAuthor | Control | - |
dc.subject.keywordPlus | VIRUS-INFECTION | - |
dc.subject.keywordPlus | RISK-FACTORS | - |
dc.subject.keywordPlus | PREVALENCE | - |
dc.relation.journalResearchArea | Gastroenterology & Hepatology | - |
dc.relation.journalWebOfScienceCategory | Gastroenterology & Hepatology | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | esci | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.